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Accessibility of Nuclear Chromatin
by DNA Binding Polyamides
nomic DNA sites in the cell nucleus. In the present study,
we address several key issues for the use of polyamides
as small molecule regulators of gene expression. Decon-
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Christian Melander,1,2 Jason M. Belitsky,2
Benjamin Edelson,2 Nicholas Wurtz,2 volution microscopy is used to monitor subcellular local-
ization, kinetics of uptake, and apoptotic effects of poly-Christoph Briehn,2 Peter B. Dervan,2,3
and Joel M. Gottesfeld1,3 amides in various cell lines. This allows us to set
parameters for time of incubation and concentration1Department of Molecular Biology
The Scripps Research Institute ranges for subsequent cell culture experiments. We as-
sess sequence-specific DNA occupancy in nuclearLa Jolla, California 92037
2 Division of Chemistry and Chemical Engineering chromatin by use of a polyamide-alkylator conjugate. In
addition, the effects of polyamides on genomic tran-California Institute of Technology
Pasadena, California 91125 scription are examined in lymphoid cells by DNA mi-
croarray analysis.
Summary Results
Pyrrole-imidazole polyamides bind DNA with affinities Polyamides and Polyamide Conjugates
comparable to those of transcriptional regulatory pro- Hairpin polyamide 1 and its chlorambucil (1-CHL) and
teins and inhibit the DNA binding activities of compo- bodipy (1-bodipy) conjugates used in this study have
nents of the transcription apparatus. If polyamides are been described previously [3, 6, 13, 14]. Based on the
to be useful for the regulation of gene expression in pairing rules for DNA recognition, polyamide 1 binds
cell culture experiments, one pivotal issue is accessi- sequences of the type 5-WGCWGCW-3 (where W 
bility of specific sites in nuclear chromatin. We first A or T), and polyamide 2 binds sequences of the type
determined the kinetics of uptake and subcellular dis- 5-WGGWGGW-3 (Figure 1A). A Kd of 0.1 nM was deter-tribution of polyamides in lymphoid and myeloid cells mined for polyamide 1 by quantitative DNase I foot-
using fluorescent polyamide-bodipy conjugates and printing [15] using a PCR fragment derived from the
deconvolution microscopy. Then cells were incubated HIV-1 promoter and enhancer (Table 1 and Figure 1B).
with a polyamide-chlorambucil conjugate, and the sites No sites for polyamide 2 are present in the region of
of specific DNA cleavage in the nuclear chromatin this DNA that can be resolved by gel electrophoresis;
were assayed by ligation-mediated PCR. In addition, however, a Kd of 0.2 nM was obtained for this polyamideDNA microarray analysis revealed that two different on a different DNA fragment [15]. For the 1-bodipy conju-
polyamides generated distinct transcription profiles. gate, a modest loss in binding affinity is observed [3]
Remarkably, the polyamides affected only a limited without loss in sequence specificity compared to the
number of genes. parent compound, whereas 1-CHL binds its target se-
quences with no loss in affinity compared to the parent
Introduction compound [13].
The development of chemical approaches for the regula-
Subcellular Localization and Kinetics oftion of gene expression in cell culture requires that se-
Polyamide Uptake in Lymphoid Cellsquence-specific DNA binding small molecules be cell
The kinetics of polyamide 1-bodipy uptake in lymphoidpermeable, transit to the nucleus, and access specific
cells were examined by deconvolution fluorescence mi-target sites in chromatin [1, 2]. Cell permeability and
croscopy (Figure 2). Previous studies indicated that thisnuclear localization of pyrrole-imidazole polyamides
polyamide-bodipy conjugate localizes in the nucleus ofhave been demonstrated for several cell lines in culture
primary human lymphocytes and T cell lines. Similarly,[3, 4]. Although several gene regulation studies using
we find that 1-bodipy localizes in the nucleus of culturedpolyamides in cell culture (and even in Drosophila) pro-
myeloid and T cell lines including the myeloid-cell linevide indirect evidence for access to nuclear chromatin
KYO1 (Figure 2A) and the T cell lines CEM (Figure 2B),[5–10], direct evidence that polyamides target se-
PM1 (Figure 2C), and MT2 (Figure 2D). In these experi-quences in nuclear DNA has been lacking. Polyamides
ments, cells were incubated in standard culture mediumbind specific DNA sites in a model nucleosome sub-
with the fluorescent 1-bodipy conjugate for 16 hr priorstrate with little loss in affinity and specificity [11, 12].
to visualization. Immediately prior to microscopy, theHowever, it is unclear how the sequence-specific bind-
cells were stained with MitoTracker (Molecular Probes)ing of polyamides is affected by both higher-order chro-
to visualize mitochondria in the cytoplasm. Note thematin structures and the large excess of competing ge-
presence of a dividing cell in Figure 2A with bright poly-
amide fluorescence staining of the chromosomes.3 Correspondence: joelg@scripps.edu (J.M.G.), dervan@caltech.edu
We next examined the time course of polyamide up-(P.B.D.)
take in unfixed lymphoid cells, again using deconvolu-4 Present address: Sidney Kimmel Cancer Center, La Jolla, California
92037. tion microscopy. Cells were first stained with Mito-
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Table 1. Effect of Competing DNA on Polyamide 1 Binding
Affinity
Competitor DNA Polyamide Concentration Required
(g/reaction) for 50% Binding (nM)a
none 0.10  0.02b
0.25 g genomic DNA 1.04 (0.15)c
0.50 g genomic DNA 2.48 (0.14)c
0.25 g poly dG-dC 0.09 (0.01)c
2.5 g poly dG-dC 0.22 (0.05)c
a Determined by DNase I footprinting and phosphorimage analysis
for binding at site A (Figure 1B and data not shown).
b Mean and standard deviation for four determinations, with a range
of 0.065 to 0.12 nM.
c Error values for each determination are given in parentheses.
Tracker, and then 1-bodipy was added to a final
concentration of 2 M in the culture medium. Images
were acquired every 2 min for 2 hr, then every 30 min
for the next 10 hr. Nuclear localization in MT2 cells is
evident after 1 hr, with intense nuclear staining after
2 hr. Video documentation of the experiment is available
as Supplemental Data at http://www.chembiol.com/cgi/
content/full/10/9/859/DC1. Note that some cells in the
field do not appear to be stained with the polyamide:
this is because the focal plane shown in this movie does
not include the nuclei of all the cells in the microscopic
field. In contrast, all of the nuclei are in the focal plane
in the microscopic images shown in Figure 2, and all of
the nuclei show bright polyamide fluorescence.
Polyamide Effects on Cell Viability,
Growth, and Apoptosis
The stability of the bodipy-polyamide in lymphoid cells
in culture was examined after 5-day incubations in stan-
dard culture media. Cells were incubated with polyam-
ide, then stained with MitoTracker prior to deconvolution
microscopy. Figure 2E demonstrates nuclear localiza-
tion in MT2 cells under these conditions. Measurements
of cell growth rates and viability (as measured by trypan
blue exclusion) indicate that polyamides at 1–2 M in
standard culture medium have no deleterious effects on
various cell lines, including CEM and MT2. We next
examined whether polyamides induce apoptosis in MT2
and KYO1 cells. Cells were incubated in culture medium
with either no polyamide or various concentrations of
polyamide 1-bodipy for 16 hr prior to staining with Alexa
Fluor 594-annexin V. Annexin V binds to phosphotidyl
Figure 1. Structures and DNA Binding Models for Synthetic Poly- serine on the surface of apoptotic cells, and such bind-
amides ing is an early marker of apoptosis. Polyamide 1-bodipy
(A) Structures of the polyamides ImPy--ImPy--ImPy--ImPy--Dp at 2 M (Figure 3B) does not induce annexin binding
(1) and ImIm--ImIm--PyPy--PyPy--Dp (2) (Im, imidazole; Py, above the level observed in the absence of polyamide
pyrrole; , -aminobutyric acid; , -alanine; Dp, dimethylaminopro-
(Figure 3A), whereas polyamide concentrations abovepylamine). Imidazole rings are shown in bold. Polyamides were also
10 M induce apoptosis (Figures 3C and 3D). As a posi-synthesized with bodipy at the N-methyl position of the indicated
tive control for annexin V binding to apoptotic cells, cellspyrrole ring (yielding polyamide 1-Bodipy) and with chlorambucil
(CHL) at the -position of the turn amino acid (yielding polyamide
1-CHL and 2-CHL). Polyamides are schematically represented at
their respective DNA binding sites, where W  A or T. The solid and
open circles represent Im and Py rings, respectively; the hairpin The Py/Py and / pairs are degenerate and target both A·T and
junction formed with -aminobutyric acid is shown as a curved line, T·A base pairs.
and the diamond represents -alanine. Base-sequence specificity (B) Sequence of the HIV-1 LTR in isolate HXB2 [16] showing the
depends on side-by-side pairing of Py and Im rings in the minor location of the TATA box and binding sites for transcriptional activa-
groove of DNA [1]. A pairing of an Im opposite a Py targets a G·C tors Ets-1, LEF-1, NF-B, and Sp1, along with the match binding
base pair, whereas a Py opposite an Im targets a C·G base pair. sites for polyamide 1 and 1-CHL (open boxes, sites A and E).
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Figure 2. Deconvolution Microscopy of Unfixed Cells
Microscopic images of KYO1 myeloid cells (A), CEM (B), PM1 (C), and MT2 (D) lymphoid cells in culture incubated with bodipy-labeled
polyamide (green) and MitoTracker Red 580 (red, mitochondrial dye). Cells were incubated with 2 M polyamide for 16 hr prior to visualization.
In (E), MT2 cells were incubated with 2 M polyamide for 5 days prior to staining with MitoTracker and visualization by deconvolution
microscopy. Images were acquired at different magnifications (ranging from 400 to 600	). The bar at the bottom of each panel corresponds
to 10 microns.
were first incubated with 1-bodipy (2 M) for 16 hr, then lated from a human T cell line (line 5.25). This competition
experiment also allows us to estimate the number ofwith 10 M camptothecin for 4 hr prior to staining with
annexin V (Figure 3E). Camptothecin induces apoptosis binding sites for this polyamide in human genomic DNA.
A radiolabeled PCR fragment (Figure 1B) was mixedthrough generation of DNA breaks by inhibition of DNA
topoisomerase I, and bright Alexa Fluor 594 fluores- with unlabeled genomic DNA prior to addition of the
cence is observed under these conditions. Cells were polyamide and incubated for 18 hr prior to digestion
also incubated with 1-bodipy (at 2 M) for 48 hr prior with DNase I and gel analysis. We expect that the con-
to staining with annexin V (Figure 3F). Again, no evidence centration of polyamide required to bind the radiola-
for apoptosis was obtained. Similar results were ob- beled DNA will increase in the presence of competing
tained with KYO1 cells (data not shown). genomic DNA. In the absence of competing DNA, 50%
binding is observed at a polyamide concentration of
0.1 nM (Table 1; representative footprints available inEffect of Competing Genomic DNA on Polyamide
Supplemental Figure S1 at Chemistry & Biology’s web-Binding Affinities
site). In reactions containing 500 ng of competing DNAFor polyamides to be useful for regulation of gene ex-
(a 1700-fold mass excess of genomic DNA over thepression in cells, these molecules must be able to ac-
radiolabeled DNA), 50% occupancy of the radiolabeledcess their desired target sites in the context of genomic
DNA is observed at a polyamide concentration of 2.5DNA where a large excess of competing sites will be
nM (Table 1). In the presence of 250 ng of competingpresent. To assess the effect of competing sites on
DNA, 50% occupancy of the radiolabeled DNA is ob-sequence-specific binding, we performed footprint titra-
tions in the presence of competing genomic DNA iso- served at a polyamide concentration of 1 nM. Based on
Figure 3. Effect of Polyamide Concentration on Cell Viability
Deconvoluted microscopic images of MT2 lymphoid cells in culture incubated with bodipy-labeled polyamide (green) and annexin V-Alexa
Fluor 594 (red). Cells were incubated with polyamide 1-bodipy for 16 hr prior to staining with annexin V. Polyamide concentrations: no
polyamide (A), 2 M (B), 10 M (C), and 40 M (D). In (E), cells were incubated with 2 M polyamide for 16 hr prior to adding 10 M camptothecin
to induce apoptosis. Four hours later, cells were stained with annexin V-Alexa Fluor 594 and visualized. In (F), cells were incubated for 48 hr
with 2 M bodipy-polyamide prior to annexin V-Alexa Fluor 594 staining and visualization.
Chemistry & Biology
862
the number of base pairs present in these amounts of residues with piperidine, and subjected to ligation-medi-
ated PCR (as described in Experimental Procedures).competing genomic DNA and the concentration of poly-
amide required for 50% occupancy of the radiolabeled The PCR products were then subjected to electrophore-
sis on a denaturing polyacrylamide gel alongside aDNA (averaged from three experiments), calculation
suggests that one match site for the polyamide occurs chemical sequencing reaction of unmodified DNA. Fig-
ure 4A shows that treatment of either purified genomicevery 1900 base pairs, or 1.3 million sites per haploid
genome. If a sequence of the form 5-WGCWGCW-3 DNA (“DNA,” lane 2) or intact cells (“cells,” lane 4) with
polyamide 1-CHL results in alkylation of A308, locatedoccurred at random in genomic DNA, we would expect
such a sequence to be present once every 2048 bp immediately adjacent to the polyamide 1 binding site
and overlapping the Ets-1 recognition site (site E; see( 44 	 23). The similarity between the calculated and
experimentally determined frequencies of occurrence of Figure 1B). Polyamide 2-CHL, a mismatch control, does
not give rise to a specific band at this position (Figurebinding sites in genomic DNA suggests that only match
sites in genomic DNA are competing for binding of poly- 4A, lanes 3 and 5), indicating a lack of binding to this
site. Additionally, alkylation with 1-CHL is observed atamide 1 to the radiolabeled DNA. Thus, the large excess
of nontarget sites in genomic DNA does not affect poly- A341, corresponding to a single nucleotide mismatch site
(Figure 4A). It is noteworthy that the band correspondingamide binding to match sites. As a control for these
experiments, we measured the binding affinity of the to A308 is fainter in the “cells” sample (compare lanes 2
and 4 in Figure 4A), indicating that access to this sitepolyamide in the presence of either 250 ng or 2.5 g of
poly(dG-dC) nontarget DNA—that is, DNA that does not by polyamide is hindered in the cell nucleus, possibly by
Ets-1 or another ets-like protein bound to its recognitioncontain polyamide binding sites—providing either an
850- or8500-fold mass excess over the radiolabeled site. This finding is consistent with previous experiments
in which inhibition of Ets-1 binding to a DNA fragmentDNA. The lower nontarget DNA concentration had no
effect on the binding affinity of the polyamide, whereas was observed only when polyamide was added to the
DNA prior to Ets-1 protein, suggesting that the poly-the higher concentration caused only a modest 2-fold
increase in the concentration of polyamide required for amide could not displace Ets-1 protein once bound to its
recognition site [17]. Alternatively, chromatin structure50% binding compared to reactions lacking competitor
DNA (Table 1), indicating that nonspecific DNA is not an might preclude polyamide binding at this site [11, 12].
Figure 4B shows alkylation at the TATA box by poly-effective competitor for sequence-specific polyamide
binding. amide 1-CHL both in purified genomic DNA (lane 2) and
in cells (lane 4). The bands correspond to positions A428
and A430, with A430 showing a slightly stronger intensity
Specific DNA Alkylation by a Polyamide-CHL of alkylation, likely due to the proximity of A430 to the
Conjugate in Nuclear Chromatin CHL moiety of the polyamide (Figure 4B). The extent of
We used the polyamide-DNA alkylator conjugate 1-CHL alkylation at this site is similar in both the in vitro and cell
to assess polyamide binding in the cell nucleus. In these culture experiments. The mismatch polyamide 2-CHL
studies, the bis(dichloroethylamino)benzene moiety of does not give rise to specific cleavage products over a
CHL was covalently linked to a hairpin polyamide at the region where no match sites for this polyamide are pres-
-amino position of the turn amino acid (Figure 1A). Free ent in the DNA sequence (lanes 3 and 5). The specific
CHL alkylates the N7 position of guanine in the major alkylation sites detected here correspond to the same
groove, but when attached to minor groove binding li- sites that were described previously with plasmid DNA
gands, alkylation is observed at the nucleophilic N3 po- containing the HIV-1 LTR [13] and with PCR products
sitions of adenine and guanine, at sites adjacent to the derived from the same cellular DNA sequence (see Sup-
polyamide binding site [13, 14]. Sequence-specific alkyl- plemental Figure S2 at Chemistry & Biology’s website).
ation of purified DNA with polyamide 1-CHL has been Because the time required for DNA extraction and LM-
observed at sites adjacent to the polyamide binding PCR spans several hours, it is conceivable that genomic
sites in the HIV-1 promoter and enhancer [13] and in DNA alkylation by the polyamide conjugate did not take
SV40 DNA [14]. To determine whether the 1-CHL conju- place in the cell nucleus but occurred after cell lysis
gate binds its nuclear target sequences in cellular chro- during the work-up of the sample. To assess this possi-
matin, we used a modified genomic DNA-footprinting bility, we added polyamide 1-CHL to radiolabeled DNA
technique, in which sites of DNA alkylation by the 1-CHL simultaneously with cell lysis buffer and incubated these
conjugate are mapped by ligation-mediated PCR using samples for 22 hr at ambient temperature prior to ther-
HIV-1 LTR-specific primers and a CEM-derived T cell mal cleavage and gel analysis (data not shown). DNA
line (5.25) that contains a stably integrated copy of the alkylation was not observed under these conditions.
HIV-1 LTR [16]. Specific alkylation of adenine or guanine This finding suggests that alkylation of genomic DNA
residues adjacent to a polyamide binding site will dem- took place in the cell nucleus rather than after cell lysis.
onstrate specific binding of the polyamide to this site. We conclude that polyamide 1-CHL specifically binds
Cells were incubated with either polyamide 1-CHL or to its target site in nuclear chromatin.
polyamide 2-CHL for 24 hr in standard culture medium.
These incubations (at polyamide concentrations up to
2 M) had no effect on cell viability, as measured by Effects of Polyamides on Genomic Transcription
The effects of polyamide treatment on nuclear transcrip-trypan blue exclusion, with approximately 95% of the
cells remaining viable (data not shown). Genomic DNA tion were monitored by DNA microarray analysis using
Affymetrix high-density U133A arrays, which contain oli-was extracted from treated cells, cleaved at modified
Chromatin Accessibility of DNA Binding Polyamides
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Figure 4. Site-Specific Alkylation by Polyam-
ide 1-CHL in Genomic DNA and in a Stably
Transfected Cell Line
Phosphorimages showing the results of poly-
amide-CHL induced alkylation with intact
cells (“cells”) and with purified genomic DNA
(“DNA”). The polyamide concentrations were
125 nM in (A) and 500 nM in (B), respectively.
In (A), the upstream region of the HIV-1 LTR
encompassing polyamide binding site E (Fig-
ure 1B) and a mismatch site is analyzed,
whereas in (B) the downstream region of the
LTR encompassing the TATA box and poly-
amide site A (Figure 1B) is analyzed. Polyam-
ide binding sites are boxed. Alkylated resi-
dues are indicated with horizontal arrows
alongside the gels. Nucleotide positions are
relative to the start of the 5 LTR in strain
HXB2. Lane 1 shows a G-ladder (denoted G).
The position of the TATA box is indicated
with a solid vertical line. One match site for
polyamide 2-CHL is present in the HIV-1 LTR
at nucleotide position 258 (Figure 1B); how-
ever, this site is distal to the region analyzed
in this experiment (A), and hence no DNA al-
kylation by this polyamide is observed. At the
bottom of each panel, the DNA sequences
encompassing each of the polyamide binding
sites are shown, along with the sites of alkyl-
ation, indicated with vertical arrows and nu-
cleotide positions. Polyamide binding models
are as in Figure 1A, with CHL denoted with a
hexagon; the single nucleotide mismatch is
boxed.
gonucleotides representing 18,000 genes. MT2 cells real-time RT-PCR of hsp70(1B) mRNA levels, where 2.7-
fold downregulation was observed for each polyamide.were treated (in triplicate) with no polyamide, polyamide
1, or polyamide 2 at a concentration of 2 M in culture Table 2 also lists the frequency of occurrence of match
binding sites for the polyamides in 3 kb of DNA sequencemedium for 48 hr. These polyamides were chosen for
this study because they contain the same number of Py upstream from the transcription start sites and 1 kb of
sequence downstream. In each instance, match sitesand Im rings but bind different sequences. Hence, we
expected that different sets of genes would be affected for the inhibitory polyamide are found in the 5 flanking
sequences of these genes. Remarkably, match sites forby the two polyamides. As before, no obvious cytotoxic-
ity was observed, and the 48 hr time point was chosen the noninhibitory polyamide are also found in most of
the affected genes (Table 2). Ongoing efforts are aimedsuch that the effects of the polyamides on new transcrip-
tion could be assessed. Based on the half-lives of mam- at assessing the mechanisms whereby these poly-
amides affect transcription in cell culture.malian mRNAs, the majority of mRNA molecules that
were present prior to polyamide treatment would be
expected to turn over during this incubation period [18]. Discussion
Total RNA was isolated and converted into fluorescent
cRNA, which was hybridized to the oligonucleotide mi- Previous polyamide binding studies have utilized short
(200–400 bp) DNA fragments and equilibrium condi-croarrays. Similar to the findings of Supekova et al. [10],
the transcription levels of a surprisingly limited number tions to measure apparent association constants for
match versus mismatch sites [1, 20]. For eight-ring hair-of genes were affected by polyamide treatment (listed
in Table 2). Using significance analysis of microarrays pin polyamides, approximately 10-fold higher concen-
trations are required to bind single nucleotide mismatchsoftware (SAM) [19], 21 genes were identified as down-
regulated for cells treated with either polyamide 1 or 2, sites compared to match sites. These differences in
affinities for match versus mismatch sites are compara-with 10 common genes between the two data sets (at
false discovery rates of 4.2% and 4.3% for polyamides ble to the binding specificities reported for natural tran-
scription factors (reviewed in [20, 21]). We find that inclu-1 and 2, respectively; Figure 5). The largest fold changes
observed were for the genes encoding heat shock pro- sion of genomic DNA in binding reactions increases the
concentration of polyamide required to bind match sitesteins hsp70(1B) and hsp70(6) (2.2- and 2.4-fold down-
regulated, respectively). This effect was validated by in a radiolabeled DNA fragment by the statistically pre-
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Figure 5. Significance Analysis of Microarray Data
(A and B) RNA from cells incubated for 48 hr with 2 M polyamide 1 or 2 was used to probe Affymetrix U133A microarray chips. Resulting
SAM analysis [19] reveals 21 significantly affected genes at a false discovery rate of 4.2% and 4.3% for 1 and 2 treated cells, respectively.
Of the 21 genes, 10 were found to be common between both groups.
(C) Venn diagram of distribution of affected genes for cells treated with polyamides 1 and 2. Models for polyamides structures are shown (as
in Figure 1A).
dicted frequency of occurrence of match sites in geno- evidence for occupancy of a predicted target site in
the cell nucleus by a polyamide at low micromolar tomic DNA. This suggests that only match sites in the
genomic DNA compete for polyamide binding to the submicromolar concentration.
radiolabeled DNA, and the large excess of nontarget
sites are without significant effect. Similar results have Significance
been reported for native and selected zinc finger pro-
teins; binding affinities in the presence of compet- Our results provide evidence for sequence-specific
ing genomic DNA suggest that these proteins have targeting by hairpin polyamides in nuclear DNA of

20,000-fold higher affinities for match sites than ran- lymphoid cells. A polyamide-chlorambucil conjugate
dom sequence DNA [21]. accesses a target site in the HIV-1 enhancer and pro-
Using deconvolution microscopy, we demonstrate moter in the nuclei of cultured cells, as determined by
that a polyamide-bodipy conjugate is rapidly taken up ligation-mediated PCR. The polyamide concentrations
in the nucleus of lymphoid and myeloid cells in culture required to observe promoter occupancy and to elicit
[3]. Nuclear localization of polyamides in lymphoid cells transcriptional effects are below those concentrations
is consistent with the inhibition of HIV-1 replication in that are toxic to the cell. Moreover, we find that the
primary peripheral blood mononuclear cells [6]. Assum- transcription profiles of only a limited number of genes
ing only match sites compete for polyamide binding are affected by polyamide treatment of cells in culture,
in vivo, we can calculate the polyamide concentration despite the large number of potential binding sites for
required to saturate all potential sites within the genome these polyamides in genomic DNA.
in a eukaryotic cell nucleus. The frequency of occur-
rence of match sites for polyamide 1 in human DNA (one Experimental Procedures
site every 2 kb) corresponds to 5 	 1018 moles of
Polyamidessites per nucleus or to a concentration of20M (based
Polyamides were synthesized by solid phase methods as describedon a 7 micron diameter T cell nuclei, corresponding to
[22]. Polyamide-bodipy conjugates were synthesized by reactinga volume of 2 	 1013 l). Results with the polyamide- the succinimidyl ester of Bodipy FL with a free amine of the precursor
bodipy conjugate (Figure 2 and data not shown) suggest polyamide (at the N-position of a pyrrole ring, pointing out of the
that polyamides are concentrated by at least 20- to 40- minor groove) [3] (Figure 1A). Polyamide-chlorambucil conjugates
were also prepared as described [13]. Polyamides were character-fold in the nucleus over the input concentration in the
ized by matrix-assisted laser desorption ionization-time of flightculture medium. Thus, 0.5 to 1 M polyamide should
mass spectrometry (MALDI-TOF MS), 1H-NMR, and analytical highbe sufficient to bind all potential match sites in living
performance liquid chromatography (HPLC). Polyamides were puri-cells. It is unclear, however, whether all match sites fied by preparative HPLC, lyophilized, and stored at 4C prior to
are available for polyamide binding in the cell nucleus, being dissolved in a buffer containing 10 mM Tris-Cl (pH 7.6) and
because location of a polyamide binding site in nucleo- 20 mM NaCl. Concentrations were determined by UV absorbance
using empirically determined extinction coefficients.somal DNA can determine polyamide accessibility in
chromatin binding [11]. Additionally, the effects of
Cell Culturehigher-order chromatin structures on polyamide binding
The human T-lymphoblastic cell line CEM was purchased from theaffinities remain unknown. In this regard, it is noteworthy
American Type Culture Collection (ATCC Number CCL-119); thethat polyamide 1-CHL was able to access only certain
human myeloid cell line KYO1 was the generous gift of Dr. P.K. Vogt
sites in cellular chromatin (Figure 4). Nevertheless, our (Scripps); the human T-lymphocyte (CD4) MT2 and PM1 cell lines
ligation-mediated PCR mapping of alkylation by a poly- were from Dr. D.E. Mosier (Scripps). Cells were cultured in RPMI
1640 medium containing 10% fetal bovine serum, 2 M glutamine,amide-CHL conjugate in genomic DNA provides direct
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10 mM HEPES, 1 mM sodium pyruvate, 100 units penicillin, and fmol) was incubated with polyamides for 18 to 22 hr at ambient
temperature in a buffer containing 10 mM Tris-Cl (pH 7.6), 10 mM100 g streptomycin sulfate per ml at 37C in 5% CO2-containing
humidified air. The cell line 5.25 (kindly obtained from Dr. N. Landau, NaCl, 5 mM MgCl2, and 2.5 mM CaCl2 in a volume of 200 l, yielding
a DNA concentration of 15 pM. In some experiments, genomicSalk Institute, La Jolla) was derived from a hybrid human CEM T cell
and B-cell line and contained the HIV-1 LTR (from strain HXB2) DNA (isolated from the 5.25 cell line) or poly(dG-dC) (Amersham
Biosciences) was included in the incubations in a total volume ofstably integrated in the genome [16]. Cells were grown in RPMI-
1640 medium supplemented with 10% fetal calf serum, 0.2 mg/ml 100 l. Digestion was allowed to proceed for 3 to 4 min at 23C
with 5 	 104 units of DNase I (Roche) diluted in 10 mM Tris-HClG418, 0.5 g/ml puromycin, and 1% penicillin/streptomycin/fun-
gizone. (pH 8), 10 mM dithiothreitol. Reactions were stopped by the addition
of 100 l of a buffer consisting of 2 M NaCl, 10 mM Tris-Cl (pH 7.6),
25 mM EDTA. Samples were subjected to ethanol precipitation usingDeconvolution Microscopy
Cells were cultured at a density of 3 	 105 cells/ml in micro-dishes 20 g of glycogen per reaction as a carrier. For polyamide-CHL
(Lab-Tek II, chamber #1.5 German coverglass system) for 24 hr prior conjugates, sites of DNA alkylation were determined by incubating
to adding the bodipy-conjugated polyamide. Micro-dishes were pre- the conjugated polyamide with singly end-labeled PCR products
coated with poly-L-lysine (Sigma, P-8920) for 15 min at 4C and for 22 hr at 37C. Reactions were stopped by the addition of cell
washed twice in cold PBS prior to use. Cell viability was assayed by lysis buffer (Qiagen) followed by ethanol precipitation as described
trypan blue exclusion. As a counterstain, mitochondria were labeled [13]. Samples were dissolved in 40 l of 10 mM sodium citrate
with MitoTracker Red 580 (M-22425, Molecular Probes). After incu- buffer (pH 7.2) and incubated for 30 min at 95C followed by ethanol
bation for 45 min, cells were washed twice in prewarmed growth precipitation. Formic acid (0.3% for 25 min at 37C) was used to
medium and visualized with a wide-field deconvolution microscope generate AG sequence markers, and dimethylsulfate (2% for 2 min
(DeltaVision, API, Issaquah, WA). Images were documented using at 23C) was used for the G-only reaction [23]. Both footprinting
a Photometrics CH350L liquid cooled CCD camera attached to an and cleavage reactions were analyzed by electrophoresis on 6%
Olympus IX-70 inverted microscope with a 60	 oil immersion objec- sequencing polyacrylamide gel containing 8.3 M urea and 88 mM
tive lens (NA 1.4) and specific filter sets. For the time-lapse study, Tris-borate (pH 8.3), 2 mM EDTA. The dried gels were exposed to
images were initially collected every 2 min for 2 hr and subsequently Kodak Bio-Max film at ambient temperature. Quantitation of the
every 30 min for 12 hr. All images were deconvolved using con- footprint titrations was by storage phosphor analysis utilizing Kodak
strained iterative algorithms (10 iterations) of DeltaVision software Storage Phosphor Screens (SO 230) and a Molecular Dynamics
(softWoRx, v2.5). This software was later used to prepare movies SF PhosphorImager. The data were analyzed using ImageQuant
to depict the progressive changes in fluorescence labeling. Adobe software from Molecular Dynamics and fit to the Langmuir isotherm
Premier software was used to annotate the movie. as described [13]. Nonlinear least square fits were performed with
KaleidaGraph software and gave correlation coefficients greater
Apoptosis Assays than 0.98.
The effect of polyamide concentration on cell viability was assessed
using annexin V-Alexa Fluor 594 conjugate (Molecular Probes). MT2 Ligation-Mediated PCR
cells grown in poly-L-lysine precoated micro-dishes (at a density of Polyamides were added directly to approximately 2 	 107 5.25 cells
6	 105 cells/ml) were incubated for various times in growth medium and incubated in a CO2 incubator at 37C for 24 hr. Genomic DNA
containing different bodipy-labeled polyamide concentrations. As a was extracted using a Qiagen genomic extraction kit. DNA (50 g)
positive control for apoptosis, cells were treated with camptothecin was cleaved with 1 M piperidine in 100 l for 30 min at 95C, precipi-
(10M, Sigma) for 4 hr prior to the experiment. As a negative control, tated with ethanol twice, and used in ligation-mediated PCR with
cells were incubated in growth medium without polyamide. After nested primers according to Garrity and Wold [25]. The upstream
incubation, cells were washed twice in cold PBS. Five microliters primer set (top strand) consisted of two primers spanning positions
of the annexin V conjugate per 100 l of annexin binding buffer 150–177 and 199–227, respectively (numbering according to Gen-
(Molecular Probes) were added, and the cells were incubated for Bank accession number K03455). The downstream primers (bottom
5 min at ambient temperature, washed in annexin binding buffer,
strand) spanned positions 520–547 and 481–510. The linker se-
and examined by deconvolution microscopy (as above). Healthy
quence was as described [25]. The upstream primer set was used
cells had either no staining or weak staining of the cellular mem-
to map alkylation near the Ets-1 site (Figure 1B), and the downstream
brane, whereas apoptotic cells exhibited a high degree of surface
primer set was used to map alkylation at the TATA box. The LM-
labeling.
PCR products were visualized by inclusion of end-labeled primer in
the last two rounds of the PCR. Purified genomic DNA from 5.25
DNA Templates for Footprinting and DNA Cleavage Reactions
cells was also incubated with polyamide-CHL, cleaved with piperi-
For DNase I footprinting and alkylation reactions, singly end-labeled
dine, and analyzed by LM-PCR as described for the cell culturePCR products were derived using genomic DNA from the 5.25 cell
experiments. The G-ladder was obtained by treating unmodifiedline as template. Genomic DNA was extracted from cells using a
genomic DNA (35 g) with dimethylsulfate followed by piperidineQiagen genomic extraction kit, and 100 ng of genomic DNA was
cleavage according to standard protocols and LM-PCR.used along with 100 ng of the primers listed below in PCR reactions
using High Fidelity PCR Master (Roche). The upstream primer 5-
Affymetrix Oligonucleotide ArrayGCTTGTTACACCCTGTGAGCCTGCATGG-3 (corresponding to nu-
Total RNA from MT2 cells from triplicate experiments was isolatedcleotide positions 199–227 of the HIV-1 HXB2 sequence in GenBank
using a Qiagen RNeasy Midi Kit according to the manufacturer’saccession number K03455) and the downstream primer 5-GCCA
instructions. Microarray experiments were performed at the DNAGAGAGCTCCCAGGCTCAGATCTG-3 (corresponding to nucleotide
Array Core Facility of The Scripps Research Institute using Affy-positions 472–498) were both obtained from Sigma Genosys (The
metrix Genechip Human Genome U133A chips. Genechip data wereWoodlands, TX). To generate radiolabeled PCR products, primers
analyzed with Affymetrix MicroArray Suite (MAS 5.0) software. RMAwere 5 end labeled with T4 polynucleotide kinase and -32P-ATP
values for probe sets were analyzed using Significance Analysis ofand used along with the respective unlabeled primer in separate
Microarrays (SAM) 1.21.PCR reactions. PCR products were separated from unincorporated
primer and purified using a PCR extraction kit from Qiagen. The
Real-Time Quantitative RT-PCRlabeled 300 bp fragment was recovered from a nondenaturing poly-
Real-time quantitative RT-PCR analysis was performed essentiallyacrylamide gel and purified by Elutip-D chromatography (Schleicher
as previously described [26]. However, the forward primer 5-AGGCand Schuell). The identity of the PCR products was confirmed by
GGACAAGAAGAAGGTGC-3 and the reverse primer 5-TGGTACMaxam-Gilbert chemical sequencing [23].
AGTCCGCTGATGATGG-3 were used to amplify a 144 bp fragment
from the 3 translated region of HSP (1B) (GenBank accession num-DNase I Footprinting and DNA Alkylation Reactions
ber NM 005346). RNA was standardized by quantification of theQuantitative footprinting was performed as described [15, 24] with
modifications noted below. The labeled DNA (10,000 cpm or 3 general housekeeping gene glyceraldehyde-3-phosphate dehydro-
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genase (GAPDH) using the forward primer 5-TGCACCACCAACTG ation of DNA by hairpin pyrrole-imidazole polyamide conju-
gates. Chem. Biol. 7, 153–161.CTTAGC-3 and the reverse primer 5-GGCATGGACTGTGGTCAT
GAG-3, as described [27]. Quantitative real-time RT-PCR was per- 14. Wang, Y.D., Dziegielewski, J., Wurtz, N.R., Dziegielewska, B.,
Dervan, P.B., and Beerman, T.A. (2003). DNA crosslinking andformed using Quantitect SYBR Green RT-PCR (Qiagen) under the
following conditions: 1 cycle at 50C for 30 min, 1 cycle at 95C for biological activity of a hairpin polyamide-chlorambucil conju-
gate. Nucleic Acids Res. 31, 1208–1215.15 min, then 45 cycles of 94C for 15 s, 60C for 30 s, and 72C for
30 s. Temperature cycling and detection of the SYBR Green emis- 15. Trauger, J.W., and Dervan, P.B. (2001). Footprinting methods
for analysis of pyrrole-imidazole polyamide/DNA complexes.sion were performed with a Cepheid SmartCycler II. Statistical analy-
sis was performed on three independent quantitative RT-PCR exper- Methods Enzymol. 340, 450–466.
16. Mariani, R., Rutter, G., Harris, M.E., Hope, T.J., Krausslich, H.G.,iments for each RNA sample.
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